Supernus Pharmaceuticals, Inc. financial data

Symbol
SUPN on Nasdaq
Location
9715 Key West Avenue, Rockville, MD
Fiscal year end
December 31
Latest financial report
10-Q - Q3 2025 - Nov 6, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 227 % +20.7%
Quick Ratio 21.4 % -9.44%
Debt-to-equity 32 % -14.3%
Return On Equity -1.83 % -129%
Return On Assets -1.39 % -130%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 57.3M shares +3.84%
Common Stock, Shares, Outstanding 57.1M shares +3.44%
Entity Public Float 1.41B USD
Common Stock, Value, Issued 57K USD +3.64%
Weighted Average Number of Shares Outstanding, Basic 56.6M shares +2.54%
Weighted Average Number of Shares Outstanding, Diluted 56.6M shares +0.96%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 682M USD +4.54%
Research and Development Expense 107M USD +3.44%
Costs and Expenses 718M USD +21.2%
Operating Income (Loss) -36.9M USD -162%
Nonoperating Income (Expense) 16.2M USD +22.7%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -20.7M USD -129%
Income Tax Expense (Benefit) -1.62M USD -113%
Net Income (Loss) Attributable to Parent -19.1M USD -132%
Earnings Per Share, Basic 0 USD/shares -131%
Earnings Per Share, Diluted 0 USD/shares -131%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 151M USD +378%
Accounts Receivable, after Allowance for Credit Loss, Current 171M USD +17.8%
Inventory, Net 107M USD +67.4%
Assets, Current 594M USD -7.21%
Deferred Income Tax Assets, Net 8.79M USD
Property, Plant and Equipment, Net 10.6M USD -10.5%
Operating Lease, Right-of-Use Asset 28.8M USD +10.3%
Intangible Assets, Net (Excluding Goodwill) 623M USD +15.4%
Goodwill 119M USD +1.76%
Other Assets, Noncurrent 62.4M USD +85.6%
Assets 1.42B USD +5.74%
Accounts Payable, Current 8.18M USD +27.9%
Employee-related Liabilities, Current 35.3M USD +74%
Accrued Liabilities, Current 109M USD +43.3%
Liabilities, Current 331M USD +13.4%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 31.4M USD +8.63%
Other Liabilities, Noncurrent 7.82M USD +6.44%
Liabilities 370M USD +10.3%
Accumulated Other Comprehensive Income (Loss), Net of Tax -71K USD -191%
Retained Earnings (Accumulated Deficit) 522M USD -3.53%
Stockholders' Equity Attributable to Parent 1.05B USD +4.22%
Liabilities and Equity 1.42B USD +5.74%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 30.6M USD -20.3%
Net Cash Provided by (Used in) Financing Activities -21.4M USD -1463%
Net Cash Provided by (Used in) Investing Activities 37.3M USD
Common Stock, Shares Authorized 130M shares 0%
Common Stock, Shares, Issued 57.1M shares +3.44%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 46.5M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 153M USD +382%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 66.7M USD +9.63%
Deferred Tax Assets, Gross 199M USD +3.79%
Operating Lease, Liability 42.2M USD +10.6%
Payments to Acquire Property, Plant, and Equipment 327K USD +31.9%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -19.3M USD -132%
Lessee, Operating Lease, Liability, to be Paid 40M USD
Property, Plant and Equipment, Gross 30.1M USD +3.33%
Operating Lease, Liability, Current 10.8M USD +16.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.96M USD
Lessee, Operating Lease, Liability, to be Paid, Year One 8.23M USD
Operating Lease, Weighted Average Discount Rate, Percent 0.05 pure 0%
Deferred Income Tax Expense (Benefit) -3.99M USD +27.2%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 5.73M USD
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.74M USD
Deferred Tax Assets, Operating Loss Carryforwards 93.1M USD -8.11%
Unrecognized Tax Benefits 5.84M USD +172%
Lessee, Operating Lease, Liability, to be Paid, Year Four 3M USD
Operating Lease, Payments 3.89M USD -2.75%
Additional Paid in Capital 528M USD +13.3%
Amortization of Intangible Assets 83.2M USD +2.94%
Depreciation, Depletion and Amortization 20.4M USD -1.76%
Deferred Tax Assets, Net of Valuation Allowance 133M USD +1.09%
Share-based Payment Arrangement, Expense 54M USD +103%
Interest Expense 0 USD -100%